APTA Stock Overview
Provides binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, the United States, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Aptamer Group PLC Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.0037 |
| 52 Week High | UK£0.014 |
| 52 Week Low | UK£0.002 |
| Beta | -0.65 |
| 1 Month Change | 27.59% |
| 3 Month Change | 60.87% |
| 1 Year Change | -68.51% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -99.74% |
Recent News & Updates
Shareholder Returns
| APTA | GB Biotechs | GB Market | |
|---|---|---|---|
| 7D | 4.2% | -1.9% | -1.2% |
| 1Y | -68.5% | -17.4% | 17.5% |
Return vs Industry: APTA underperformed the UK Biotechs industry which returned -17.4% over the past year.
Return vs Market: APTA underperformed the UK Market which returned 17.5% over the past year.
Price Volatility
| APTA volatility | |
|---|---|
| APTA Average Weekly Movement | 10.9% |
| Biotechs Industry Average Movement | 8.3% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in GB Market | 10.4% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: APTA's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: APTA's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 34 | Arron Tolley | aptamergroup.com |
Aptamer Group PLC, together with its subsidiaries, provides binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, the United States, and internationally. The company offers Optimer, a platform that enables the discovery and development of optimized DNA and RNA aptamers; and Optimer +, a platform that discovers and develops of hybrid DNA-protein molecules that combines the features of Optimer and antibodies. It serves bioprocessing and diagnostic institutes, as well as pharmaceutical scientists.
Aptamer Group PLC Fundamentals Summary
| APTA fundamental statistics | |
|---|---|
| Market cap | UK£7.11m |
| Earnings (TTM) | -UK£2.96m |
| Revenue (TTM) | UK£860.00k |
8.3x
P/S Ratio-2.4x
P/E RatioIs APTA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| APTA income statement (TTM) | |
|---|---|
| Revenue | UK£860.00k |
| Cost of Revenue | UK£610.00k |
| Gross Profit | UK£250.00k |
| Other Expenses | UK£3.21m |
| Earnings | -UK£2.96m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0015 |
| Gross Margin | 29.07% |
| Net Profit Margin | -343.95% |
| Debt/Equity Ratio | 5.3% |
How did APTA perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/17 03:39 |
| End of Day Share Price | 2024/12/17 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Aptamer Group PLC is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Alistair Campbell | Panmure Liberum |
| Edward Thomason | Panmure Liberum |